These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 583447)

  • 41. [Clinico-bacteriological study of 20 Serratia marcescens infections treated with amikacin].
    Pérez González F; Prendes Peláez P; Meana Fonseca JL; Martín Alvarez R
    Rev Clin Esp; 1981 Jun 15-30; 161(5-6):327-34. PubMed ID: 7027369
    [No Abstract]   [Full Text] [Related]  

  • 42. Amikacin levels in the human biliary tract.
    LeFrock JL; Schell RF; Siskind S; Carr BB
    J Clin Pharmacol; 1984; 24(5-6):247-54. PubMed ID: 6747021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amikacin concentrations in uninfected postthoracotomy pleural fluid and in serum after intravenous and intrapleural injection.
    Thys JP; Serruys-Schoutens E; Rocmans P; Herchuelz A; Vanderlinden MP; Yourassowsky E
    Chest; 1984 Apr; 85(4):502-5. PubMed ID: 6705579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses.
    Xerri L; Orsolini P; Broggio R
    Chemioterapia; 1984 Oct; 3(5):271-7. PubMed ID: 6398124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Determination of gentamicin in the cerebrospinal fluid (CSF) after lumbar injections. Results observed in 22 adult patients and children. Therapeutic implications].
    Mariel C; Veyssier P; Péchère JC
    Sem Hop; 1972 Dec; 48(53):3543-7. PubMed ID: 4346840
    [No Abstract]   [Full Text] [Related]  

  • 46. [Diffusion of amikacin in the lungs].
    Saux MC; Crockett R; Fourtillan JB; Leng B; Couraud L
    Pathol Biol (Paris); 1986 Feb; 34(2):113-7. PubMed ID: 3517776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ceftriaxone by systemic route combined with amikacin by intraventricular route in the treatment of ventriculitis in children with hydrocephalus].
    Prado V; Zuleta A; Basauri L; Aguirre X
    Bol Med Hosp Infant Mex; 1984 Sep; 41(9):476-80. PubMed ID: 6093832
    [No Abstract]   [Full Text] [Related]  

  • 48. [Study of the local use of amikacin].
    Wada S; Nishio S; Kishimoto T; Maekawa M; Yuki K; Sasaki S; Oshima N; Hayahara N; Nishijima T; Funai K
    Hinyokika Kiyo; 1985 May; 31(5):907-13. PubMed ID: 4050636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraventricular levels of amikacin after intravenous administration.
    Yogev R; Kolling WM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):583-6. PubMed ID: 7325626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Localized lipoatrophy after intramuscular amikacin.
    Kumar V; Kumar M; Grover C
    Indian J Dermatol Venereol Leprol; 2009; 75(5):552. PubMed ID: 19736463
    [No Abstract]   [Full Text] [Related]  

  • 51. [Morphological studies of the effect of amikacin on the neurosecretory system of the albino rat].
    Siuda S; Mariak Z; Woroniecka G
    Patol Pol; 1982; 33(3-4):205-15. PubMed ID: 7162850
    [No Abstract]   [Full Text] [Related]  

  • 52. [Peritoneal transfer of amikacin: its use in peritoneal dialysis. Preliminary study].
    Slingeneyer A; Liendo-Liendo C; Despaux E; Balmayer B; Perez C; Mion C
    Nouv Presse Med; 1979 Oct; 8(42):3432-5. PubMed ID: 537890
    [No Abstract]   [Full Text] [Related]  

  • 53. Lean body mass and amikacin dosage.
    Hallynck TH; Soep HH; Thomis JA; Boelaert J; Daneels R; Rubinstein E; Reeves DS; Fillastre JP
    J Antimicrob Chemother; 1980 Mar; 6(2):286-8. PubMed ID: 7380773
    [No Abstract]   [Full Text] [Related]  

  • 54. The pharmacokinetics of amikacin in children.
    Vogelstein B; Kowarski A; Lietman PS
    J Pediatr; 1977 Aug; 91(2):333-9. PubMed ID: 874697
    [No Abstract]   [Full Text] [Related]  

  • 55. Massive amikacin "overdose".
    Ho PW; Pien FD; Kominami N
    Ann Intern Med; 1979 Aug; 91(2):227-8. PubMed ID: 464467
    [No Abstract]   [Full Text] [Related]  

  • 56. Patients' perceptions of pain with spinal, intramuscular, and venous injections.
    Simini B
    Lancet; 2000 Mar; 355(9209):1076. PubMed ID: 10744099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Amikacin in lumbar and ventricular cerebrospinal fluid: Concentrations after intramuscular or intrathecal injection. Study of 16 patients. Therapeutic implications].
    Veyssier P; Dusehu E; Preux MC; Lehtihet R; Manuel C; Pangon B; Lavalard JF
    Nouv Presse Med; 1979 Oct; 8(42):3436-40. PubMed ID: 583447
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparative pharmacokinetics of amikacin after intravenous, intramuscular and subcutaneous administration].
    Leng B; Saux MC; Latrille J
    Nouv Presse Med; 1979 Oct; 8(42):3421-5. PubMed ID: 537887
    [No Abstract]   [Full Text] [Related]  

  • 59. Intraventricular cerebrospinal fluid antibiotic concentrations in patients with intraventricular infections.
    James HE; Wilson HD; Connor JD; Walsh JW
    Neurosurgery; 1982 Jan; 10(1):50-4. PubMed ID: 7057978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Molina HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):271-5. PubMed ID: 7107075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.